Document:

EX 10.39 Second Loan Amendment

Exhibit 10.39

SECOND AMENDMENT
TO
AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT 
AND 
FIRST AMENDMENT TO DISBURSEMENT LETTER
THIS SECOND AMENDMENT to Amended and Restated Loan and Security Agreement and First Amendment to Disbursement Letter (this “Amendment”) is entered into as of January 23, 2015, by and among OXFORD FINANCE LLC (“Oxford”) as collateral agent (in such capacity, the “Collateral Agent”), the Lenders listed on Schedule 1.1 of the Loan Agreement or otherwise a party thereto from time to time including, without limitation, Oxford in its capacity as a Lender, and SILICON VALLEY BANK (in such capacity, each a “Lender” and collectively, the “Lenders”), and HALOZYME THERAPEUTICS, INC., a Delaware corporation, and HALOZYME, INC., a California corporation (individually and collectively, jointly and severally, “Borrower”).
Recitals
A.Collateral Agent, Lenders and Borrower have entered into that certain Amended and Restated Loan and Security Agreement dated as of December 27, 2013 (as the same has been and may from time to time further be amended, modified, supplemented or restated, collectively, the “Loan Agreement”).  Lenders have extended credit to Borrower for the purposes permitted in the Loan Agreement.
B.Collateral Agent, Lenders and Borrower have entered into that certain Disbursement Letter dated as of December 27, 2013 (as the same may from time to time be amended, modified, supplemented or restated, collectively, the “Disbursement Letter”).
C.Borrower has requested that Collateral Agent and Lenders amend the Loan Agreement and the Disbursement Letter to make certain revisions to the Loan Agreement and Disbursement Letter as more fully set forth herein.
D.Collateral Agent and Lenders have agreed to so amend certain provisions of the Loan Agreement and Disbursement Letter, but only to the extent, in accordance with the terms, subject to the conditions and in reliance upon the representations and warranties set forth below.
Agreement
Now, Therefore, in consideration of the foregoing recitals and other good and valuable consideration, the receipt and adequacy of which is hereby acknowledged, and intending to be legally bound, the parties hereto agree as follows:
1.Definitions.  Capitalized terms used but not defined in this Amendment shall have the meanings given to them in the Loan Agreement.
2.Amendments to Loan Agreement.  
2.1Section 2.2 (Term Loans).  Section 2.2(b) hereby is amended by deleting the reference to “thirty-six (36) months” and replacing it with “twenty-four (24) months”.

2.2Section 2.5 (Fees).  Section 2.5 hereby is amended to delete the word “and” at the end of clause (e) (First Amendment Fee), change the title “(f) Fees Fully Earned.” to “(g) Fees Fully Earned.” and insert the following new clause (f) as the penultimate paragraph of such Section:
(f)    Second Amendment Fee.  On the Second Amendment Effective Date, a fully earned non-refundable fee of One Hundred Eighty Thousand Dollars ($180,000.00) (the “Second Amendment Fee”) to be shared between the Lenders pursuant to their respective Commitment Percentages; and
2.3Section 13.1 (Definitions).  The following term and its definition hereby are amended in Section 13.1 of the Loan Agreement as follows:
“Amortization Date” is February 1, 2016.
2.3Section 13.1 (Definitions).  The following terms and their respective definitions hereby are added to Section 13.1 in their appropriate alphabetical order:
“Second Amendment Effective Date” means January 23, 2015.
“Second Amendment Fee” is defined in Section 2.5(f).
3.Amendment to Disbursement Letter.  The Disbursement Letter hereby is amended by replacing the Amortization Table with the Amortization Table attached hereto as Exhibit A.
4.Limitation of Amendments.
4.1The amendments set forth in Sections 2 and 3, above, are effective for the purposes set forth herein and shall be limited precisely as written and shall not be deemed to (a) be a consent to any amendment, waiver or modification of any other term or condition of any Loan Document, or (b) otherwise prejudice any right or remedy which Collateral Agent or any Lender may now have or may have in the future under or in connection with any Loan Document.
4.2This Amendment shall be construed in connection with and as part of the Loan Documents and all terms, conditions, representations, warranties, covenants and agreements set forth in the Loan Documents, except as herein amended, are hereby ratified and confirmed and shall remain in full force and effect.
5.Representations and Warranties.  To induce Collateral Agent and Lenders to enter into this Amendment, Borrower hereby represents and warrants to Collateral Agent and Lenders as follows:
5.1Immediately after giving effect to this Amendment (a) the representations and warranties contained in the Loan Documents (as such may be modified by the updated Perfection Certificate delivered to the Collateral Agent on or around the date hereof) are true, accurate and complete in all material respects as of the date hereof (except to the extent such representations and warranties relate to an earlier date, in which case they are true and correct in all material respects as of such date), and (b), no Event of Default has occurred and is continuing;
5.2Borrower has the power and authority to execute and deliver this Amendment and to perform its obligations under the Loan Agreement, as amended by this Amendment;
5.3The organizational documents of Borrower most recently delivered to Collateral Agent and Lenders are true, accurate and complete and have not been amended, supplemented or restated and are and continue to be in full force and effect;
5.4The execution and delivery by Borrower of this Amendment and the performance by Borrower of its obligations under the Loan Agreement, as amended by this Amendment, have been duly authorized;
5.5The execution and delivery by Borrower of this Amendment and the performance by Borrower of its obligations under the Loan Agreement, as amended by this Amendment, do not and will not contravene (a) any material Requirement of Law binding on or affecting Borrower, (b) any material agreement by which Borrower is bound in a manner that constitutes an event of default thereunder, (c) any order, judgment or decree of any court or other governmental or public body or authority, or subdivision thereof, binding on Borrower, or (d) the organizational documents of Borrower;

5.6The execution and delivery by Borrower of this Amendment and the performance by Borrower of its obligations under the Loan Agreement, as amended by this Amendment, do not require any order, consent, approval, license, authorization or validation of, or filing, recording or registration with, or exemption by any governmental or public body or authority, or subdivision thereof, binding on Borrower, except as already has been obtained or made or is being obtained pursuant to Section 6.1(b) of the Loan Agreement; and
5.7This Amendment has been duly executed and delivered by Borrower and is the binding obligation of Borrower, enforceable against Borrower in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization, liquidation, moratorium or other similar laws of general application and equitable principles relating to or affecting creditors’ rights.
6.Counterparts.  This Amendment may be executed in any number of counterparts and all of such counterparts taken together shall be deemed to constitute one and the same instrument.
7.Effectiveness.  This Amendment shall be deemed effective upon (a) the due execution and delivery to Collateral Agent and Lenders of this Amendment; (b) Borrower’s payment of the Second Amendment Fee in an amount equal to One Hundred Eighty Thousand Dollars ($180,000.00); and (c) Borrower’s payment of all Lenders’ Expenses incurred through the date of this Amendment.
[Balance of Page Intentionally Left Blank]

In Witness Whereof, the parties hereto have caused this Amendment to be duly executed and delivered as of the date first written above.
	
					
	COLLATERAL AGENT:
OXFORD FINANCE LLC
	 
	BORROWER:
HALOZYME THERAPEUTICS, INC.

	By:
	/s/ Mark Davis
	 
	By:
	/s/ David A. Ramsay

	Name:
	Mark Davis
	 
	Name:
	David A. Ramsay

	Title:
	Vice President - Finance, Secretary & Treasurer
	 
	Title:
	CFO

	 
	 
	 
	 
	 

	LENDERS:
OXFORD FINANCE LLC
	 
	HALOZYME, INC.

	By:
	/s/ Mark Davis
	 
	By:
	/s/ David A. Ramsay

	Name:
	Mark Davis
	 
	Name:
	David A. Ramsay

	Title:
	Vice President - Finance, Secretary & Treasurer
	 
	Title:
	CFO

	 
	 
	 
	 
	 

	SILICON VALLEY BANK
	 
	 
	 

	By:
	/s/ Anthony Flores
	 
	 
	 

	Name:
	Anthony Flores
	 
	 
	 

	Title:
	Vice President
	 
	 
	 

[SIGNATURE PAGE TO SECOND AMENDMENT TO 
AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT 
AND FIRST AMENDMENT TO DISBURSEMENT LETTER]

Exhibit A
AMORTIZATION TABLE
	
							
	Oxford Finance & SVB

	Amortization Table

	Halozyme AA01

	 
	 
	 
	 
	 
	 
	 

	 
	 
	 
	 
	 
	 
	 

	 
	Start Date:
	12/27/2013
	 
	Disclaimer:
	 
	 

	 
	Interest Rate:
	7.55%
	 
	THIS IS A STANDARD AMORTIZATION

	 
	Term:
	48
	24 IO + 24 PI
	SCHEDULE.  IT IS NOT INTENDED TO BE 

	 
	Payment:
	$1,350,669.95 
	 
	USED FOR PAYOFF PURPOSES.
	 

	 
	Final Payment:
	$2,550,000.00 
	8.50%
	 
	 
	 

	 
	Amount:
	30,000,000.00
	 
	 
	 
	 

	 
	 
	 
	 
	 
	 
	 

	 
	 
	 
	 
	 
	 
	 

	PMT
	Payment
	Beginning
	Monthly
	 
	 
	Ending

	No.
	Date
	Balance
	Payment
	Interest
	Principal
	Balance

	 
	 
	 
	 
	 
	 
	 

	 
	 
	 
	 
	 
	 
	 

	 
	1/1/14
	Interim Interest Due
	$30,000,000.00 

	1
	2/1/14
	$30,000,000.00 
	$188,750.00 
	$188,750.00 
	$0.00 
	$30,000,000.00 

	2
	3/1/14
	$30,000,000.00 
	$188,750.00 
	$188,750.00 
	$0.00 
	$30,000,000.00 

	3
	4/1/14
	$30,000,000.00 
	$188,750.00 
	$188,750.00 
	$0.00 
	$30,000,000.00 

	4
	5/1/14
	$30,000,000.00 
	$188,750.00 
	$188,750.00 
	$0.00 
	$30,000,000.00 

	5
	6/1/14
	$30,000,000.00 
	$188,750.00 
	$188,750.00 
	$0.00 
	$30,000,000.00 

	6
	7/1/14
	$30,000,000.00 
	$188,750.00 
	$188,750.00 
	$0.00 
	$30,000,000.00 

	7
	8/1/14
	$30,000,000.00 
	$188,750.00 
	$188,750.00 
	$0.00 
	$30,000,000.00 

	8
	9/1/14
	$30,000,000.00 
	$188,750.00 
	$188,750.00 
	$0.00 
	$30,000,000.00 

	9
	10/1/14
	$30,000,000.00 
	$188,750.00 
	$188,750.00 
	$0.00 
	$30,000,000.00 

	10
	11/1/14
	$30,000,000.00 
	$188,750.00 
	$188,750.00 
	$0.00 
	$30,000,000.00 

	11
	12/1/14
	$30,000,000.00 
	$188,750.00 
	$188,750.00 
	$0.00 
	$30,000,000.00 

	12
	1/1/15
	$30,000,000.00 
	$188,750.00 
	$188,750.00 
	$0.00 
	$30,000,000.00 

	13
	2/1/15
	$30,000,000.00 
	$188,750.00 
	$188,750.00 
	$0.00 
	$30,000,000.00 

	14
	3/1/15
	$30,000,000.00 
	$188,750.00 
	$188,750.00 
	$0.00 
	$30,000,000.00 

	15
	4/1/15
	$30,000,000.00 
	$188,750.00 
	$188,750.00 
	$0.00 
	$30,000,000.00 

	16
	5/1/15
	$30,000,000.00 
	$188,750.00 
	$188,750.00 
	$0.00 
	$30,000,000.00 

	17
	6/1/15
	$30,000,000.00 
	$188,750.00 
	$188,750.00 
	$0.00 
	$30,000,000.00 

	18
	7/1/15
	$30,000,000.00 
	$188,750.00 
	$188,750.00 
	$0.00 
	$30,000,000.00 

	19
	8/1/15
	$30,000,000.00 
	$188,750.00 
	$188,750.00 
	$0.00 
	$30,000,000.00 

	
							
	20
	9/1/15
	$30,000,000.00 
	$188,750.00 
	$188,750.00 
	$0.00 
	$30,000,000.00 

	21
	10/1/15
	$30,000,000.00 
	$188,750.00 
	$188,750.00 
	$0.00 
	$30,000,000.00 

	22
	11/1/15
	$30,000,000.00 
	$188,750.00 
	$188,750.00 
	$0.00 
	$30,000,000.00 

	23
	12/1/15
	$30,000,000.00 
	$188,750.00 
	$188,750.00 
	$0.00 
	$30,000,000.00 

	24
	1/1/16
	$30,000,000.00 
	$188,750.00 
	$188,750.00 
	$0.00 
	$30,000,000.00 

	25
	2/1/16
	$30,000,000.00 
	$1,350,669.95 
	$188,750.00 
	$1,161,919.95 
	$28,838,080.05 

	26
	3/1/16
	$28,838,080.05 
	$1,350,669.95 
	$181,439.59 
	$1,169,230.36 
	$27,668,849.68 

	27
	4/1/16
	$27,668,849.68 
	$1,350,669.95 
	$174,083.18 
	$1,176,586.77 
	$26,492,262.91 

	28
	5/1/16
	$26,492,262.91 
	$1,350,669.95 
	$166,680.49 
	$1,183,989.46 
	$25,308,273.45 

	29
	6/1/16
	$25,308,273.45 
	$1,350,669.95 
	$159,231.22 
	$1,191,438.73 
	$24,116,834.72 

	30
	7/1/16
	$24,116,834.72 
	$1,350,669.95 
	$151,735.09 
	$1,198,934.87 
	$22,917,899.85 

	31
	8/1/16
	$22,917,899.85 
	$1,350,669.95 
	$144,191.79 
	$1,206,478.16 
	$21,711,421.69 

	32
	9/1/16
	$21,711,421.69 
	$1,350,669.95 
	$136,601.03 
	$1,214,068.92 
	$20,497,352.76 

	33
	10/1/16
	$20,497,352.76 
	$1,350,669.95 
	$128,962.51 
	$1,221,707.44 
	$19,275,645.32 

	34
	11/1/16
	$19,275,645.32 
	$1,350,669.95 
	$121,275.94 
	$1,229,394.02 
	$18,046,251.31 

	35
	12/1/16
	$18,046,251.31 
	$1,350,669.95 
	$113,541.00 
	$1,237,128.95 
	$16,809,122.36 

	36
	1/1/17
	$16,809,122.36 
	$1,350,669.95 
	$105,757.39 
	$1,244,912.56 
	$15,564,209.80 

	37
	2/1/17
	$15,564,209.80 
	$1,350,669.95 
	$97,924.82 
	$1,252,745.13 
	$14,311,464.67 

	38
	3/1/17
	$14,311,464.67 
	$1,350,669.95 
	$90,042.97 
	$1,260,626.99 
	$13,050,837.68 

	39
	4/1/17
	$13,050,837.68 
	$1,350,669.95 
	$82,111.52 
	$1,268,558.43 
	$11,782,279.25 

	40
	5/1/17
	$11,782,279.25 
	$1,350,669.95 
	$74,130.17 
	$1,276,539.78 
	$10,505,739.47 

	41
	6/1/17
	$10,505,739.47 
	$1,350,669.95 
	$66,098.61 
	$1,284,571.34 
	$9,221,168.13 

	42
	7/1/17
	$9,221,168.13 
	$1,350,669.95 
	$58,016.52 
	$1,292,653.44 
	$7,928,514.70 

	43
	8/1/17
	$7,928,514.70 
	$1,350,669.95 
	$49,883.57 
	$1,300,786.38 
	$6,627,728.32 

	44
	9/1/17
	$6,627,728.32 
	$1,350,669.95 
	$41,699.46 
	$1,308,970.49 
	$5,318,757.82 

	45
	10/1/17
	$5,318,757.82 
	$1,350,669.95 
	$33,463.85 
	$1,317,206.10 
	$4,001,551.72 

	46
	11/1/17
	$4,001,551.72 
	$1,350,669.95 
	$25,176.43 
	$1,325,493.52 
	$2,676,058.20 

	47
	12/1/17
	$2,676,058.20 
	$1,350,669.95 
	$16,836.87 
	$1,333,833.08 
	$1,342,225.12 

	48
	1/1/18
	$1,342,225.12 
	$1,350,669.95 
	$8,444.83 
	$1,342,225.12 
	$0.00 

	Final
	1/1/18
	Final
	$2,550,000.00 
	$2,550,000.00 
	$0.00 
	 

	 
	 
	 
	 
	 
	 
	 

	 
	 
	Totals
	$39,496,078.83 
	$9,496,078.83 
	$30,000,000.00 
	 

	
							
	Oxford Finance & SVB

	Amortization Table

	Halozyme AA02

	 
	 
	 
	 
	 
	 
	 

	 
	 
	 
	 
	 
	 
	 

	 
	Start Date:
	12/27/2013
	 
	Disclaimer:
	 
	 

	 
	Interest Rate:
	7.55%
	 
	THIS IS A STANDARD AMORTIZATION

	 
	Term:
	48
	24 IO + 24 PI
	SCHEDULE.  IT IS NOT INTENDED TO BE 

	 
	Payment:
	$900,446.63 
	 
	USED FOR PAYOFF PURPOSES.
	 

	 
	Final Payment:
	$1,700,000.00 
	8.50%
	 
	 
	 

	 
	Amount:
	20,000,000.00
	 
	 
	 
	 

	 
	 
	 
	 
	 
	 
	 

	 
	 
	 
	 
	 
	 
	 

	PMT
	Payment
	Beginning
	Monthly
	 
	 
	Ending

	No.
	Date
	Balance
	Payment
	Interest
	Principal
	Balance

	 
	 
	 
	 
	 
	 
	 

	 
	 
	 
	 
	 
	 
	 

	 
	1/1/14
	Interim Interest Due
	$20,000,000.00 

	1
	2/1/14
	$20,000,000.00 
	$125,833.33 
	$125,833.33 
	$0.00 
	$20,000,000.00 

	2
	3/1/14
	$20,000,000.00 
	$125,833.33 
	$125,833.33 
	$0.00 
	$20,000,000.00 

	3
	4/1/14
	$20,000,000.00 
	$125,833.33 
	$125,833.33 
	$0.00 
	$20,000,000.00 

	4
	5/1/14
	$20,000,000.00 
	$125,833.33 
	$125,833.33 
	$0.00 
	$20,000,000.00 

	5
	6/1/14
	$20,000,000.00 
	$125,833.33 
	$125,833.33 
	$0.00 
	$20,000,000.00 

	6
	7/1/14
	$20,000,000.00 
	$125,833.33 
	$125,833.33 
	$0.00 
	$20,000,000.00 

	7
	8/1/14
	$20,000,000.00 
	$125,833.33 
	$125,833.33 
	$0.00 
	$20,000,000.00 

	8
	9/1/14
	$20,000,000.00 
	$125,833.33 
	$125,833.33 
	$0.00 
	$20,000,000.00 

	9
	10/1/14
	$20,000,000.00 
	$125,833.33 
	$125,833.33 
	$0.00 
	$20,000,000.00 

	10
	11/1/14
	$20,000,000.00 
	$125,833.33 
	$125,833.33 
	$0.00 
	$20,000,000.00 

	11
	12/1/14
	$20,000,000.00 
	$125,833.33 
	$125,833.33 
	$0.00 
	$20,000,000.00 

	12
	1/1/15
	$20,000,000.00 
	$125,833.33 
	$125,833.33 
	$0.00 
	$20,000,000.00 

	13
	2/1/15
	$20,000,000.00 
	$125,833.33 
	$125,833.33 
	$0.00 
	$20,000,000.00 

	14
	3/1/15
	$20,000,000.00 
	$125,833.33 
	$125,833.33 
	$0.00 
	$20,000,000.00 

	15
	4/1/15
	$20,000,000.00 
	$125,833.33 
	$125,833.33 
	$0.00 
	$20,000,000.00 

	16
	5/1/15
	$20,000,000.00 
	$125,833.33 
	$125,833.33 
	$0.00 
	$20,000,000.00 

	17
	6/1/15
	$20,000,000.00 
	$125,833.33 
	$125,833.33 
	$0.00 
	$20,000,000.00 

	18
	7/1/15
	$20,000,000.00 
	$125,833.33 
	$125,833.33 
	$0.00 
	$20,000,000.00 

	19
	8/1/15
	$20,000,000.00 
	$125,833.33 
	$125,833.33 
	$0.00 
	$20,000,000.00 

	20
	9/1/15
	$20,000,000.00 
	$125,833.33 
	$125,833.33 
	$0.00 
	$20,000,000.00 

	21
	10/1/15
	$20,000,000.00 
	$125,833.33 
	$125,833.33 
	$0.00 
	$20,000,000.00 

	22
	11/1/15
	$20,000,000.00 
	$125,833.33 
	$125,833.33 
	$0.00 
	$20,000,000.00 

	
							
	23
	12/1/15
	$20,000,000.00 
	$125,833.33 
	$125,833.33 
	$0.00 
	$20,000,000.00 

	24
	1/1/16
	$20,000,000.00 
	$125,833.33 
	$125,833.33 
	$0.00 
	$20,000,000.00 

	25
	2/1/16
	$20,000,000.00 
	$900,446.63 
	$125,833.33 
	$774,613.30 
	$19,225,386.70 

	26
	3/1/16
	$19,225,386.70 
	$900,446.63 
	$120,959.72 
	$779,486.91 
	$18,445,899.79 

	27
	4/1/16
	$18,445,899.79 
	$900,446.63 
	$116,055.45 
	$784,391.18 
	$17,661,508.61 

	28
	5/1/16
	$17,661,508.61 
	$900,446.63 
	$111,120.32 
	$789,326.31 
	$16,872,182.30 

	29
	6/1/16
	$16,872,182.30 
	$900,446.63 
	$106,154.15 
	$794,292.49 
	$16,077,889.81 

	30
	7/1/16
	$16,077,889.81 
	$900,446.63 
	$101,156.72 
	$799,289.91 
	$15,278,599.90 

	31
	8/1/16
	$15,278,599.90 
	$900,446.63 
	$96,127.86 
	$804,318.78 
	$14,474,281.13 

	32
	9/1/16
	$14,474,281.13 
	$900,446.63 
	$91,067.35 
	$809,379.28 
	$13,664,901.84 

	33
	10/1/16
	$13,664,901.84 
	$900,446.63 
	$85,975.01 
	$814,471.63 
	$12,850,430.22 

	34
	11/1/16
	$12,850,430.22 
	$900,446.63 
	$80,850.62 
	$819,596.01 
	$12,030,834.21 

	35
	12/1/16
	$12,030,834.21 
	$900,446.63 
	$75,694.00 
	$824,752.64 
	$11,206,081.57 

	36
	1/1/17
	$11,206,081.57 
	$900,446.63 
	$70,504.93 
	$829,941.70 
	$10,376,139.87 

	37
	2/1/17
	$10,376,139.87 
	$900,446.63 
	$65,283.21 
	$835,163.42 
	$9,540,976.45 

	38
	3/1/17
	$9,540,976.45 
	$900,446.63 
	$60,028.64 
	$840,417.99 
	$8,700,558.45 

	39
	4/1/17
	$8,700,558.45 
	$900,446.63 
	$54,741.01 
	$845,705.62 
	$7,854,852.83 

	40
	5/1/17
	$7,854,852.83 
	$900,446.63 
	$49,420.12 
	$851,026.52 
	$7,003,826.32 

	41
	6/1/17
	$7,003,826.32 
	$900,446.63 
	$44,065.74 
	$856,380.89 
	$6,147,445.42 

	42
	7/1/17
	$6,147,445.42 
	$900,446.63 
	$38,677.68 
	$861,768.96 
	$5,285,676.47 

	43
	8/1/17
	$5,285,676.47 
	$900,446.63 
	$33,255.71 
	$867,190.92 
	$4,418,485.55 

	44
	9/1/17
	$4,418,485.55 
	$900,446.63 
	$27,799.64 
	$872,647.00 
	$3,545,838.55 

	45
	10/1/17
	$3,545,838.55 
	$900,446.63 
	$22,309.23 
	$878,137.40 
	$2,667,701.15 

	46
	11/1/17
	$2,667,701.15 
	$900,446.63 
	$16,784.29 
	$883,662.35 
	$1,784,038.80 

	47
	12/1/17
	$1,784,038.80 
	$900,446.63 
	$11,224.58 
	$889,222.06 
	$894,816.75 

	48
	1/1/18
	$894,816.75 
	$900,446.63 
	$5,629.89 
	$894,816.75 
	$0.00 

	Final
	1/1/18
	Final
	$1,700,000.00 
	$1,700,000.00 
	$0.00 
	 

	 
	 
	 
	 
	 
	 
	 

	 
	 
	Totals
	$26,330,719.22 
	$6,330,719.22 
	$20,000,000.00EX-4.1

 Exhibit 4.1 
 

 
  
 NUMBER 
SHARES 
BLUE BIRD CORPORATION 
INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE 
CUSIP 095306 10 6 
C O M M O N S T O C K 
THIS CERTIFIES THAT: 
PROOF 
IS THE OWNER OF 
FULLY PAID AND NON-ASSESSABLE COMMON STOCK OF $.0001 PAR VALUE PER SHARE EACH OF 
BLUE BIRD
CORPORATION (THE “CORPORATION”) 
transferable on the books of the Corporation in person or by duly authorized attorney upon surrender of this certificate
properly endorsed. 
This certificate is not valid unless countersigned by the Transfer Agent and registered by the Registrar of the Corporation. 
Witness the seal of the Corporation and the facsimile signatures of its duly authorized officers. 
DATED: 
COUNTERSIGNED: 
BY: 
CONTINENTAL STOCK TRANSFER & TRUST COMPANY NEW YORK, NY TRANSFER AGENT 
AUTHORIZED OFFICER 
SECRETARY 
CHIEF EXECUTIVE OFFICER AND PRESIDENT 

 BLUE BIRD CORPORATION 

The Corporation will furnish without charge to each stockholder who so requests the powers, designations, preferences and relative, participating, optional or
other special rights of each class of stock or series thereof of the Corporation and the qualifications, limitations, or restrictions of such preferences and/or rights. This certificate and the shares represented thereby are issued and shall be held
subject to all the provisions of the Certificate of Incorporation and all amendments thereto and resolutions of the Board of Directors providing for the issue of securities (copies of which may be obtained from the secretary of the Corporation), to
all of which the holder of this certificate by acceptance hereof assents. 
 The following
abbreviations, when used in the inscription on the face of this certificate,
shall be construed as though they were written out in full according to
applicable laws or regulations: 
  

													
	 TEN COM
	 	- as tenants in common	  	 	UNIF GIFT MIN ACT -	  	  	  
	  	Custodian	  	  

	 TEN ENT
	 	- as tenants by the entireties	  				  	(Cust)	  		  	(Minor)
	 JT TEN
	 	- as joint tenants with right of 	  				  	under Uniform Gifts to Minors
		 	survivorship and not as tenants	  				  	Act	  	  

		 	in common	  				  		  	(State)

 Additional abbreviations
may also be used though
not in the above list. 

For Value
Received,                        
hereby sells, assigns and
transfers unto 
     PLEASE INSERT SOCIAL SECURITY OR
OTHER 
             IDENTIFYING NUMBER OF ASSIGNEE 

					
	  

     

  
	  		  	

  

	
	  

 

	 (PLEASE PRINT OR TYPE NAME AND ADDRESS, INCLUDING ZIP CODE, OF ASSIGNEE)

	
	  

	
	  

	                         
                                                
                                                
                                           
     Shares of the capital stock represented by the within Certificate, and do hereby irrevocably constitute and appoints

                             
                                                
                                                 
                                               
                    Attorney to transfer the said stock on the books of the within named Corporation with full power of substitution in the
premises.

 Dated
                                        

  

					
	 	  	 	  	                                     
                                         
                                         
                          
	Signature(s) Guaranteed	  		  	NOTICE: THE SIGNATURE TO THIS ASSIGNMENT MUST CORRESPOND WITH THE NAME AS WRITTEN UPON THE FACE OF THE CERTIFICATE IN EVERY PARTICULAR, WITHOUT ALTERATION OR ENLARGEMENT OR ANY CHANGE
WHATSOEVER.

  

			
	By	 	  

	The Signature(s) must be guaranteed by an eligible guarantor institution (Banks, Stockbrokers, Savings and Loan Associations and Credit Unions with membership in
an approved Signature Guarantee Medallion Program), pursuant to SEC Rule 17Ad-15.

  

			
	 	  	COLUMBIA FINANCIAL PRINTING CORP. -www.stockinformation.com

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00241-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00241-of-00352.parquet"}]]